Citation Impact

Citing Papers

Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
CD8 + T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection
2002
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Mutagenicity of heterocyclic nitrogen mustards (ICR compounds) in cultured mammalian cells.
1978
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers
2003
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Serum Hbv Dna As A Marker of Efficacy During Therapy for Chronic Hbv Infection: Analysis and Review of the Literature
2003
Surveillance for Hepatocellular Carcinoma and Early Diagnosis
2007
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Molecular viral oncology of hepatocellular carcinoma
2003
Hepatitis B virus infection
2009 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B
2005
Characterization of Liver T–Cell Receptor γδ+ T Cells Obtained From Individuals Chronically Infected With Hepatitis C Virus (Hcv): Evidence for These T Cells Playing A Role in the Liver Pathology Associated With Hcv Infections
2001 StandoutNobel
Selection and Analysis of a Mutant Cell Line Defective in the Hypoxia-inducible Factor-1 α-Subunit (HIF-1α)
1998 StandoutNobel
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
2005
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
1996
Hepatitis B Virus Transgenic Mice: Models of Viral Immunobiology and Pathogenesis
1996
Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting
1989 StandoutNatureNobel
The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection
2007
Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor
2001 StandoutNobel
Repopulation of Mouse Liver With Human Hepatocytes And In Vivo Infection With Hepatitis B Virus
2001
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Hepatocellular Carcinoma
2011 Standout
Kinetics of the Immune Response During Hbv and Hcv Infection
2003
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Iron-Catalyzed Reactions in Organic Synthesis
2004 Standout
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host
2012 StandoutNobel
Beta-agonist- and prostaglandin E1-induced translocation of the beta-adrenergic receptor kinase: evidence that the kinase may act on multiple adenylate cyclase-coupled receptors.
1986 StandoutNobel
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
1981 Standout
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
1986 Standout
Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells
1986
Epoxides of Carcinogenic Polycyclic Hydrocarbons Are Frameshift Mutagens
1972 Science
Adenylate cyclase permanently uncoupled from hormone receptors in a novel variant of S49 mouse lymphoma cells.
1977 StandoutNobel
Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids.
1975 Standout
Charles S. Mott prize papillomaviruses in human cancer
1987 StandoutNobel
Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
1991 StandoutNobel
Cytoplasmic transfer of chloramphenicol resistance in human tissue culture cells.
1975
Biochemical prophage induction assay: a rapid test for antitumor agents that interact with DNA.
1983
RELATION BETWEEN AFLATOXIN, HEPATITIS-B VIRUS, AND HEPATOCELLULAR CARCINOMA
1979
Advances in Transition Metal (Pd,Ni,Fe)-Catalyzed Cross-Coupling Reactions Using Alkyl-organometallics as Reaction Partners
2011 Standout
Association of human hepatocellular carcinoma and cirrhosis with hepatitis b virus surface and core antigens in the liver
1977
Unrevealing the natural course of the so-called “inactive HBsAg or HBV carrier state”
2007
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Calicheamicin γ 1 I : an Antitumor Antibiotic That Cleaves Double-Stranded DNA Site Specifically
1988 StandoutScience
Comparative sequence analysis of duck and human hepatitis B virus genomes
1985
Revertants of a trans-dominant S49 mouse lymphoma mutant that affects expression of cAMP-dependent protein kinase
1983
Hepatocyte turnover during resolution of a transient hepadnaviral infection
2003
Cloning in Escherichia coli and physical structure of hepatitis B virion DNA.
1979
Woodchuck hepatitis virus X protein is required for viral infection in vivo
1994
Hepatitis B virus genes and their expression in E. coli
1979 StandoutNatureNobel
Geographic correlation between mortality from primary hepatic carcinoma and prevalence of hepatitis B surface antigen in Greece
1976
Fc-receptor variants of a mouse macrophage cell line
1979
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles
1997 StandoutNobel
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
Cloned duck hepatitis B virus DNA is infectious in Pekin ducks
1984
Zanvil Alexander Cohn 1926-1993.
1994 StandoutNobel
Hepatocarcinogenicity of the woodchuck hepatitis virus.
1987
ProTox-II: a webserver for the prediction of toxicity of chemicals
2018 Standout
A novel catecholamine-activated adenosine cyclic 3',5'-phosphate independent pathway for .beta.-adrenergic receptor phosphorylation in wild-type and mutant S49 lymphoma cells: mechanism of homologous desensitization of adenylate cyclase
1986 StandoutNobel
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
Serological relationship of woodchuck hepatitis virus to human hepatitis B virus
1979
A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B
2005
Mitochondrial Diseases in Man and Mouse
1999 StandoutScience
Hepatitis-B surface antigen and antibody in Bantu patients with primary hepatocellular cancer
1976
DNA sequence of a mutation in the leader region of the yeast iso-1-cytochrome c mRNA
1981 StandoutNobel
Viral dynamics in hepatitis B virus infection.
1996
Duck hepatitis B virus DNA in liver and serum of Chinese ducks: integration of viral DNA in a hepatocellular carcinoma.
1985
The Role of Viruses in Human Tumors
1980 StandoutNobel
Association of hepatitis b virus infection with hepatocellular carcinoma in american patients
1980
Viruses in Human Cancers
1991 StandoutScienceNobel
Transcripts and the putative RNA pregenome of duck hepatitis B virus: Implications for reverse transcription
1985
Mutagenicity and cytotoxicity of nineteen heterocyclic mustards (ICR compounds) in cultured mammalian cells.
1979
Somatic genetic analysis of cyclic AMP action: Selection of unresponsive mutants
1975
Carcinogens are Mutagens: A Simple Test System Combining Liver Homogenates for Activation and Bacteria for Detection
1973 Standout
A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan
1991 StandoutNobel
An Efficient Synthesis of 2-Substituted 6-Methylpurine Bases and Nucleosides by Fe- or Pd-Catalyzed Cross-Coupling Reactions of 2,6-Dichloropurines
2003
Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma
1980 Nature
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Molecular Cloning of Complementary DNA for the Alpha Subunit of the G Protein that Stimulates Adenylate Cyclase
1985 StandoutScienceNobel
Isolation and characterization of a hepatitis B virus endemic in herons
1988
Molecular Mechanisms of Cyclic AMP Action: A Genetic Approach
1976
Arene Oxides: A New Aspect of Drug Metabolism
1974 StandoutScience
MUTANTS OF YEAST DEFECTIVE IN ISO-1-CYTOCHROME c
1974
Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.
1975 Standout
An Improved Bacterial Test System for the Detection and Classification of Mutagens and Carcinogens
1973
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
Dynamics of hepatitis B virus clearance in chimpanzees
2005
Mutations Affecting the Structure and Function of Immunoglobulin M
1982 StandoutNobel
Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte
1994
Mutagenicity of chloroacetaldehyde, a possible metabolic product of 1,2-dichloroethane (ethylene dichloride), chloroethanol (ethylene chlorohydrin), vinyl chloride, and cyclophosphamide.
1975
Mutagenesis in S49 mouse lymphoma cells: induction of resistance to ouabain, 6-thioguanine, and dibutyryl cyclic AMP.
1977
Carcinogens as Frameshift Mutagens: Metabolites and Derivatives of 2-Acetylaminofluorene and Other Aromatic Amine Carcinogens
1972
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel

Works of Anna P. O’Connell being referenced

Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.
1998
ANTIBODY TO HEPATITIS-B CORE ANTIGEN IN PATIENTS WITH PRIMARY HEPATIC CARCINOMA
1975
Naturally occurring infection of Pekin duck embryos by duck hepatitis B virus.
1983
Mixed bifunctionality. 4. Antitumor activity of alkylating derivatives of polycyclic aromatic hydrocarbons as a function of structure and of vehicle
1972
Sequence of events in natural infection of Pekin duck embryos with duck hepatitis B virus
1985
Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement
1992
Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.
1994
Hepatitis B virus DNA in primary hepatocellular carcinoma tissue
1978
Antitumor and mutagenic properties of a variety of heterocyclic nitrogen and sulfur mustards
1972
Duck hepatitis B virus and liver diseases
1983
Association of e antigen with Dane particle DNA in sera from asymptomatic carriers of hepatitis B surface antigen.
1977
Rankless by CCL
2026